Do you have pilot and demonstration infrastructure relevant for the bioeconomy that is not yet included in the Pilots4U database? Pilots4U, a network of bioeconomy open access pilot and multipurpose demo facilities, is compiling a database on bioeconomy pilot-scale equipment hosted at open access facilities across the EU.
Meet our Business Development Team at RAFT 2017.
Bio Base NWE, coordinated by Bio Base Europe Pilot Plant, won the RegioStars Award 2017. Fyteko, a Belgian start-up, testifies how the cooperation with Bio Base Europe Pilot Plant helped them to convince investors.
Pilots4U is a European project funded by the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme. The purposes of the project is to map open access pilot and demo-infrastructures across Europe, to help companies and research institutions operating in the bioeconomy gain easier access to testing facilities to bring their ideas from development to market.
ReSolve sets out to replace two hazardous solvents – toluene and NMP (N-methyl-2-pyrrolidone) – with safer alternatives derived from non-food carbohydrates.
ERDF Flanders and Bio Base Europe Pilot Plant (BBEPP) signed an agreement for an investment of €9,36 million within the framework of the IMPACT project.
EFRO Vlaanderen en Bio Base Europe Pilot Plant (BBEPP) ondertekenden een overeenkomst voor een investering van 9,36 miljoen EURO in het kader van het IMPACT project.
Opbouw van nieuwe demonstratie apparatuur – Building new demonstration equipment
ReSolve, a €4.3 million EU project focused on replacing traditional, fossil-based solvents, was officially launched Thursday June 15. Led by the University of York, the project consortium is comprised of 11 partners from 5 different countries.
Rehap aims to strengthen the European bio-economy industry by creating novel materials from agricultural and forestry waste, and considering how they can be used commercially in the green building sector.
Falcon: Fuel And chemicals from Lignin through enzymatic and chemical CONversion.
FALCON aims to convert this lignin-rich industrial waste of 2G biofuel plants to higher value products, in particular shipping fuels, fuel additives and chemical building blocks. This would be the next consecutive step in turning waste to products, thus minimizing waste and simultaneously providing new alternatives for fossil resource based processes.
The main objective of DAFIA is to exploit the organic fraction of municipal solid wastes (MSW) and marine rest raw materials (MRRM) as feedstocks for higher value products.
DuPont Industrial Biosciences has been awarded a grant from the European Commission to demonstrate high-efficiency enzyme production to increase biogas yields as part of the DEMETER project, funded from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 Research and Innovation program.
NanoPack: Pilot line manufacturing of functional polymer nanocomposites from natural halloysite nanotubes: demonstrating controlled release of active antimicrobials in food packaging applications.
NanoPack aims to develop and demonstrate state-of-the-art antimicrobial packaging solutions for perishable foods based on natural nanomaterials that will prevent food-borne illness outbreaks and reduce food waste caused by early spoilage.
Demeter: Demonstrating more efficient enzyme production to increase biogas yields.
DEMETER will increase the yield of the fermentation process at an industrial scale as well as the down-stream processing of a C1-based biogas enzyme, reducing the cost of the end product and making the enzyme available for wide-spread application in biogas production throughout Europe.
On November 3rd, 2016, Inbiose, a Belgium-based producer of specialty carbohydrates and DuPont Nutrition & Health (DuPont, USA) announced a joint development and licensing agreement for exclusive rights to selected fucosylated human milk oligosaccharides (HMOs), including 2’-fucosyllactose. HMOs are a group of unique oligosaccharides found in mother’s milk, with 2’-fucosyllactose being the single most abundant […]
(AMES, USA, 31.10.2016) REG Life Sciences, LLC, a wholly owned subsidiary of Renewable Energy Group has delivered its first commercial product, a specialty fatty acid. REG developed, produced and delivered approximately one metric ton of the renewable, multi-functional chemical to Aroma Chemical Services International (ACS), a leading specialty manufacturer and supplier of flavor and fragrance […]
What a nice experience for a start-up to conduct a feasibility study! by Dr Pattanathu Rahman, Founder TeeGene Biotech Ltd. ‘It was one of the great moments, when I met a Bio Base Europe Pilot Plant (BBEPP) facilities representative at the Industrial Biotech Leadership Forum (IBLF) at London in Feb 2015. I picked up a […]
In 2014, the feasibility of Celtic Renewables’ innovative process to produce biobutanol from byproducts of the whisky industry was evaluated at Bio Base Europe Pilot Plant, using a Bio Base NWE Innovation Coupon. This assessment enabled Celtic Renewables to gather a next round of investments worth €1,5million and was the start of a succesful collaboration. In September […]
The MARISURF project will use marine bacterial strains to produce new SAs. To ensure the newly discovered SAs satisfy their requirements and demands, MARISURF will place the industrial end-users in a leading role in guiding the search for new SAs.
The CARBOSURF project aims to develop new biobased processes as well as products and solves bottlenecks in the fermentative production of biobased biosurfactants and specialty carbohydrates. Specifically, it targets different glycolipid biosurfactants with a wide range of application fields and specialty carbohydrates, i.e. complex Human Milk Oligosaccharides that find applications as neutraceutical, pharmaceutical and cosmetic ingredients. The project is coordinated by Prof. Soetaert from Ghent University (Belgium).
Sugar beet pulp (SBP) accounts for approx. 13 million tonnes in Europe and is a major residual stream from the sugar beet industry, which is currently valorised as low value feed and/or green gas. In order to increase the value of its side streams, PULP2VALUE developed multiple extraction techniques to isolate more valuable products from this large fraction of sugar beet pulp.
Pectcof B.V. (The Netherlands) is a start-up company that developed the technology to transform coffee pulp biomass into valuable compounds. To speed up this innovation from the laboratory to an industrial process, we were introduced to Bio Base Europe Pilot Plant. Here we did two production runs under the support of innovation vouchers from Bio Base North […]
The Nano3Bio project aims to develop biotechnological production systems for nanoformulated chitosans. Chitosans are among the most versatile and most promising biopolymers and have excellent physico-chemical and material properties as well as a wide range of biological functionalities.
2G BIOPIC proposes a new approach: bioethanol production from lignocellulosic biomass. This technology is based on a highly effective clean deconstruction of lignocellulosic biomass, an advanced organosolv technology, for which several patents have been submitted in the past decade by CIMV. An original and efficient biomass refining technology allows optimal extraction of the three main biomass components and downstream biotechnological transformation.
The RenewPACK project will demonstrate the material Skalax as a barrier in food packaging for the first time ever. RenewPACK is a project partly financed by the European Commission through LIFE+. The project is conducted by Xylophane AB (as coordinating beneficiary) and Bio Base Europe Pilot Plant (as associated beneficiary).
IB2Market aims to bring industrial biotechnology from the research lab to the market and to solve the bottle-necks in industrialization. The project covers process development, scale up, market exploration and the drafting of a valorization plan to support a successful market introduction.
Eco Treasures BVBA is a company specialising in the revalorisation of natural side streams. It specializes in extraction technology more specific supercritical CO2 extraction. Supercritical CO2 extraction is a green extraction technology with a lot of potential for natural “waste streams”.
The project aims to accelerate the growth of the biobased economy, EU and local partners joined forces by providing financial, technological, training, networking and political support to enterprises in North West Europe (NWE) innovating in biobased products and processes.
This project aims to create new-to-nature and tailor-made biosurfactants through metabolic engineering of the unconventional yeast Starmerella bombicola.
Surfactants or surface active agents are applied in a wide range of industries and products e.g. cleaning, personal care, cosmetics, agriculture, oil recovery, paper industry. Surfactants are produced in large amounts of which the majority is used in households for laundry and cleaning. This results in large volumes of waste water ending up in the environment.
The ChitoBioEngineering project aims at establishing biotechnological ways of producing fully defined, partially acetylated chitosan oligomers. This will be achieved through genetic, metabolic, and enzyme engineering.
Industrial biotechnology plays a crucial role in the development of sustainable and cost effective production processes for biobased chemicals. These processes typically consist of two distinct unit operations: fermentation, followed by purification of the compound of interest from the fermentation broth. Product recovery and purification (also called downstream processing or DSP) are important cost factors, responsible for up to 80% of the total production cost. Reducing DSP cost is therefore a key success factor to improve the overall economics of biobased processes.
The goal of the Novosides project is the development of biocatalytic processes for the glycosylation of small organic molecules such as flavonoids, alkaloids and steroids. Glycosylation can drastically improve both the physicochemical and biological properties of these molecules (e.g. slow release, improved solubility and stability, taste modification, drug targeting), but few biocatalysts are currently available to perform this modification cost-efficiently at industrial scale.